Abstract
The collagen vascular diseases are a heterogeneous group of immunologically-mediated inflammatory disorders. Frequently, these diseases affect organ systems outside the thorax as their primary manifestation, but may involve the pleura as a single presenting feature, as part of multisystem involvement, or as an isolated manifestation of a disease that is otherwise quiescent. In this article, we review the manifestations of respiratory disease caused by rheumatoid arthritis, systemic lupus erythematosus, scleroderma, polymyositis / dermatomyositis, mixed connective tissue disease, Sjogrens syndrome, Wegeners granulomatosis, and sarcoidosis.
Keywords: pleura, collagen diseases, rheumatoid arthritis
Current Drug Targets - Inflammation & Allergy
Title: Pleural Involvement in Systemic Disorders
Volume: 3 Issue: 4
Author(s): Marina Aiello, Alfredo Chetta, Emilio Marangio, Maurizio Zompatori and Dario Olivieri
Affiliation:
Keywords: pleura, collagen diseases, rheumatoid arthritis
Abstract: The collagen vascular diseases are a heterogeneous group of immunologically-mediated inflammatory disorders. Frequently, these diseases affect organ systems outside the thorax as their primary manifestation, but may involve the pleura as a single presenting feature, as part of multisystem involvement, or as an isolated manifestation of a disease that is otherwise quiescent. In this article, we review the manifestations of respiratory disease caused by rheumatoid arthritis, systemic lupus erythematosus, scleroderma, polymyositis / dermatomyositis, mixed connective tissue disease, Sjogrens syndrome, Wegeners granulomatosis, and sarcoidosis.
Export Options
About this article
Cite this article as:
Aiello Marina, Chetta Alfredo, Marangio Emilio, Zompatori Maurizio and Olivieri Dario, Pleural Involvement in Systemic Disorders, Current Drug Targets - Inflammation & Allergy 2004; 3(4) . https://dx.doi.org/10.2174/1568010042634604
DOI https://dx.doi.org/10.2174/1568010042634604 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Recent Updates on Current and Upcoming Biomarkers for Cardiovascular Diseases
Current Pharmaceutical Design Secondary Prevention of Ischemic Stroke
Current Drug Targets Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?
Current Pharmaceutical Design Guide of Hypertensive Crisis Pharmacotherapy
Cardiovascular & Hematological Disorders-Drug Targets Intracranial Collateral Flow Estimated by Color Velocity Imaging Quantification Ultrasound: A Protector of Recurrent Stroke in Patient with Carotid Stenosis?
Current Neurovascular Research The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
Current Pharmaceutical Design Asthma COPD Overlap Syndrome: An Approach to A Real -World Endotype in Obstructive Lung Disease?
Current Pharmaceutical Design L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management
Current Medicinal Chemistry HIV-Induced Abnormalities in Myelopoiesis and their Recovery Following Antiretroviral Therapy
Current HIV Research The Pathophysiology of CTGs and Types of Intrapartum Hypoxia
Current Women`s Health Reviews Post-stroke Depression Therapy: Where are we now?
Current Neurovascular Research GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants
Current Pharmaceutical Design Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes
Drug Metabolism Letters Reactive Oxygen Species, Vascular Disease and Cardiovascular Surgery
Current Vascular Pharmacology Rheumatoid Arthritis: Notable Biomarkers Linking to Chronic Systemic Conditions and Cancer
Current Pharmaceutical Design Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Inflammatory Responses in Brain Ischemia
Current Medicinal Chemistry Fetal Determinants of Type 2 Diabetes
Current Drug Targets